Sign In
Buy EVLVW
Evolv Technology Earnings Calls
| Release date | May 12, 2026 |
| EPS estimate | -$0.0300 |
| EPS actual | -$0.0200 |
| EPS Surprise | 33.33% |
| Revenue estimate | 44.226M |
| Revenue actual | 46.328M |
| Revenue Surprise | 4.75% |
| Release date | Mar 10, 2026 |
| EPS estimate | -$0.0375 |
| EPS actual | -$0.0300 |
| EPS Surprise | 20.00% |
| Revenue estimate | 36.453M |
| Revenue actual | 38.504M |
| Revenue Surprise | 5.63% |
| Release date | Nov 13, 2025 |
| EPS estimate | -$0.0333 |
| EPS actual | -$0.0104 |
| EPS Surprise | 68.83% |
| Revenue estimate | 33.675M |
| Revenue actual | 42.85M |
| Revenue Surprise | 27.25% |
| Release date | Aug 14, 2025 |
| EPS estimate | -$0.0350 |
| EPS actual | -$0.245 |
| EPS Surprise | -600.83% |
| Revenue estimate | 30.933M |
| Revenue actual | 32.544M |
| Revenue Surprise | 5.21% |
Last 4 Quarters for Evolv Technology
Below you can see how EVLVW performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 14, 2025 |
| Price on release | $0.675 |
| EPS estimate | -$0.0350 |
| EPS actual | -$0.245 |
| EPS surprise | -600.83% |
| Date | Price |
|---|---|
| Aug 08, 2025 | $0.640 |
| Aug 11, 2025 | $0.669 |
| Aug 12, 2025 | $0.720 |
| Aug 13, 2025 | $0.720 |
| Aug 14, 2025 | $0.675 |
| Aug 15, 2025 | $0.760 |
| Aug 18, 2025 | $0.83 |
| Aug 19, 2025 | $0.80 |
| Aug 20, 2025 | $0.84 |
| 4 days before | 5.53% |
| 4 days after | 24.09% |
| On release day | 12.54% |
| Change in period | 30.96% |
| Release date | Nov 13, 2025 |
| Price on release | $0.350 |
| EPS estimate | -$0.0333 |
| EPS actual | -$0.0104 |
| EPS surprise | 68.83% |
| Date | Price |
|---|---|
| Nov 07, 2025 | $0.460 |
| Nov 10, 2025 | $0.503 |
| Nov 11, 2025 | $0.459 |
| Nov 12, 2025 | $0.381 |
| Nov 13, 2025 | $0.350 |
| Nov 14, 2025 | $0.252 |
| Nov 17, 2025 | $0.200 |
| Nov 18, 2025 | $0.204 |
| Nov 19, 2025 | $0.150 |
| 4 days before | -23.91% |
| 4 days after | -57.14% |
| On release day | -28.00% |
| Change in period | -67.39% |
| Release date | Mar 10, 2026 |
| Price on release | $0.0760 |
| EPS estimate | -$0.0375 |
| EPS actual | -$0.0300 |
| EPS surprise | 20.00% |
| Date | Price |
|---|---|
| Mar 04, 2026 | $0.0662 |
| Mar 05, 2026 | $0.0883 |
| Mar 06, 2026 | $0.0503 |
| Mar 09, 2026 | $0.0625 |
| Mar 10, 2026 | $0.0760 |
| Mar 11, 2026 | $0.104 |
| Mar 12, 2026 | $0.0700 |
| Mar 13, 2026 | $0.0680 |
| Mar 16, 2026 | $0.0615 |
| 4 days before | 14.80% |
| 4 days after | -19.08% |
| On release day | 36.84% |
| Change in period | -7.10% |
| Release date | May 12, 2026 |
| Price on release | $0.130 |
| EPS estimate | -$0.0300 |
| EPS actual | -$0.0200 |
| EPS surprise | 33.33% |
| Date | Price |
|---|---|
| May 06, 2026 | $0.135 |
| May 07, 2026 | $0.139 |
| May 08, 2026 | $0.140 |
| May 11, 2026 | $0.133 |
| May 12, 2026 | $0.130 |
| May 13, 2026 | $0.0802 |
| May 14, 2026 | $0.0800 |
| May 15, 2026 | $0.0688 |
| May 18, 2026 | $0.0616 |
| 4 days before | -3.70% |
| 4 days after | -52.62% |
| On release day | -38.31% |
| Change in period | -54.37% |
Evolv Technology Earnings Call Transcript Summary of Q1 2026
Evolv reported strong Q1 2026 results with revenue of $46.3M (+45% YoY) and ARR of $127.3M (+20% YoY). Adjusted EBITDA expanded to $3.9M (8.5% margin). The company is raising 2026 revenue guidance to $175M–$180M (previously $172M–$178M) and expects to exit 2026 with ARR of ~$145M–$150M. Key drivers are continued demand across education, healthcare, sports/entertainment and enterprise, growth of the Expedite bag-screening product (75+ customers, ~6% of base), and an increasing mix of purchase subscriptions (guidance reflects ~55% purchase / 45% subscription for the year). Management reiterated a target to be comfortably over 10,000 deployed units by year-end and sees improving long-term margin leverage driven by scale, higher adoption of Expedite, direct fulfillment, and operational improvements (Plexus manufacturing partnership onboarding complete by quarter-end). Q1 gross margin was 52% (down YoY due to direct fulfillment timing), but management expects full-year gross margins in the mid-50s and full-year adjusted EBITDA margins in the high single digits for 2026. Cash was $61M; company expects to be cash-flow positive in H2 2026. Management will provide more detail at Investor Day on June 9.
